NEWS: 公告在东京证券交易所JASDAQ标准市场新上市

表纸
市场调查报告书

人体生长荷尔蒙(hGH)的全球市场:各应用领域(生长激素缺乏症,透纳氏症,特发性矮小症,普拉达威利症候群,小于胎龄儿),地区 2014年~2025

Human Growth Hormone Market Size, Share & Trends Analysis Report By Application (Growth Hormone Deficiency, Turner Syndrome), By Distribution Channel, By Region, And Segment Forecasts, 2020 - 2027

出版商 Grand View Research, Inc. 商品编码 600786
出版日期 内容资讯 英文 120 Pages
商品交期: 2-10个工作天内
价格
人体生长荷尔蒙(hGH)的全球市场:各应用领域(生长激素缺乏症,透纳氏症,特发性矮小症,普拉达威利症候群,小于胎龄儿),地区 2014年~2025 Human Growth Hormone Market Size, Share & Trends Analysis Report By Application (Growth Hormone Deficiency, Turner Syndrome), By Distribution Channel, By Region, And Segment Forecasts, 2020 - 2027
出版日期: 2020年02月05日内容资讯: 英文 120 Pages
简介

生长激素缺乏症,普拉达威利症候群,原发性矮小症,小于胎龄儿(SGA)是治疗使用生长激素(GH)的疾病。克雅氏病,慢性肾脏病,SHOX遗传基因单套缺失症候群,关于努南氏症候群等其他的适应症也接受核准。全球人体生长荷尔蒙(hGH)市场预计2025年达到71亿美元。脑垂体功能不全的案例增加,人体生长荷尔蒙的使用增加,预计今后数年促进市场成长。

本报告提供全球人体生长荷尔蒙(hGH)市场相关调查,市场概要,各应用领域、地区的市场趋势,市场规模的变化与预测,市场成长要素分析,竞争情形,主要企业的简介等,全面性资讯。

目录

第1章 摘要整理

  • 市场概述

第2章 调查方法

  • 资讯采购
  • 资料分析

第3章 人体生长荷尔蒙(hGH)市场趋势与范围

  • 市场区隔和范围
  • 渗透与成长预测制图
  • 人体生长荷尔蒙 - SWOT分析
  • 产业分析 - 波特的五力分析
  • 竞争情形:市场地位分析

第4章 人体生长荷尔蒙(hGH)市场趋势分析与预测:各应用领域

  • 市场分析:各应用领域
  • 生长激素缺乏症
  • 透纳氏症
  • 原发性矮小症
  • 普拉达威利症候群
  • 小于胎龄儿
  • 其他

第5章 人体生长荷尔蒙(hGH)市场趋势分析与预测:各地区

  • 市场分析
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
  • 亚太地区
    • 日本
    • 中国
  • 中南美
    • 巴西
    • 墨西哥
  • 中东、非洲
    • 南非

第6章 竞争情形

  • 策略架构
  • 企业简介
目录
Product Code: GVR-2-68038-057-6

The global human growth hormone market size is expected to reach a value of USD 8.5 billion by 2027, registering a CAGR of 8.2% over the forecast period, according to a new report by Grand View Research, Inc. Introduction of novel therapies, increasing R&D activities, and rising awareness for the diagnosis and treatment of growth hormone (GH) disorders are expected to drive the market over the forecast period.

Key players operating in the market are involved in extensive R&D activities for the development of novel GH therapies to strengthen their position in the market. For instance, in October 2019, VISEN Pharmaceuticals, a joint venture of Denmark-based Ascendis Pharma A/S, received approval from China National Drug Administration (NMPA) for its new drug (IND) application to start Phase III clinical study of TransCon hGH. Furthermore, two South Korean companies, Genexine Inc. and Handok Inc., are conducting a Phase II clinical trial study on GX-H9, a recombinant human GH for the treatment of adult and pediatric GH deficiency.

Furthermore, increase in the number of regulatory approvals and launch of novel hGH therapies are expected to fuel the market over the forecast period. For instance, in January 2018, Ferring Pharmaceuticals Inc., a Switzerland-based pharmaceutical company, received United States Food and Drug Administration (USFDA) approval for its new recombinant hGH, Zomacton (somatropin) indicated for the treatment of adult patients with GH deficiency.

Various government and private organizations have been undertaking initiatives and programs to spread awareness about GH deficiency and facilitate timely diagnosis and treatment. Nonprofit organizations such as Human Growth Foundation are engaged in providing research support and spreading awareness about GH deficiency and its treatment. Such initiatives are expected to drive the demand for hGH treatment therapies.

Further key findings from the study suggest:

  • GH deficiency was the largest application segment in 2019 owing to increase in regulatory approvals and launch of novel therapies
  • Rising awareness about GH deficiency, coupled with increasing hospital visits for its treatment, is expected to drive the hospital distribution channel segment
  • North America dominated the human growth hormone market with the largest share in 2019. This is attributed to favorable reimbursement scenario, high awareness, and the presence of major players in the region
  • Asia Pacific is projected to witness a lucrative CAGR over the forecast period owing to increasing penetration of key players with their new growth hormone therapies

The key players include Novo Nordisk A/S; Pfizer Inc.; Eli Lilly and Company; Sandoz International GmbH (Novartis AG); Merck KGaA; Genentech, Inc. (Roche); Ferring Pharmaceuticals; Teva Pharmaceutical Industries, Ltd; and Ipsen.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market segmentation & scope
  • 1.2 Market definition
  • 1.3 Information procurement
    • 1.3.1 Purchased database
    • 1.3.2 GVR's internal database
    • 1.3.3 Secondary sources & third party perspectives
    • 1.3.4 Primary research
  • 1.4 Information analysis
    • 1.4.1 Data analysis models
  • 1.5 Market formulation & data visualization
  • 1.6 Data validation & publishing

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook
  • 2.3 Competitive Insights

Chapter 3 Human Growth Hormone (hGH) Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Ancillary Market Outlook
  • 3.2 Penetration and Growth Prospect Mapping
  • 3.3 Market Dynamics
    • 3.3.1 Market driver analysis
      • 3.3.1.1 Increasing R&D investments
      • 3.3.1.2 Introduction of novel therapies
      • 3.3.1.3 Increasing awareness regarding GH deficiency
      • 3.3.1.4 Robust pipeline
      • 3.3.1.5 Strategic initiatives by key players
    • 3.3.2 Market Restraint Analysis
      • 3.3.2.1 Adverse effects related to hormone therapies
      • 3.3.2.2 Stringent regulatory scenario
      • 3.3.2.3 High treatment cost
    • 3.3.3 Industry challenges
  • 3.4 Human Growth Hormone (hGH) Market Analysis Tools
    • 3.4.1 Industry analysis - Porter's
      • 3.4.1.1 Supplier Power
      • 3.4.1.2 Buyer Power
      • 3.4.1.3 Substitution Threat
      • 3.4.1.4 Threat from new entrants
      • 3.4.1.5 Competitive Rivalry
    • 3.4.2 PESTEL Analysis
      • 3.4.2.1 Political Landscape
      • 3.4.2.2 Environmental Landscape
      • 3.4.2.3 Social landscape
      • 3.4.2.4 Technology landscape
      • 3.4.2.5 Legal Landscape
    • 3.4.3 Major deals and strategic alliances analysis
      • 3.4.3.1 Joint ventures
      • 3.4.3.2 Mergers and acquisitions
      • 3.4.3.3 Licensing and partnership
      • 3.4.3.4 Technology collaborations
      • 3.4.3.5 Strategic Divestments
    • 3.4.4 Market entry strategies

Chapter 4 Human Growth Hormone (hGH) Market - Competitive Analysis

  • 4.1 Recent Developments & Impact Analysis, by Key Market Participants
  • 4.2 Vendor Landscape
    • 4.2.1 List of key distributors and channel partners
    • 4.2.2 Key company market share analysis, 2019
  • 4.3 Public Companies
    • 4.3.1 Company market position analysis
    • 4.3.2 Competitive dashboard analysis
  • 4.4 Private Companies
    • 4.4.1 List of key emerging companies
    • 4.4.2 Regional network map
    • 4.4.3 Company market position analysis

Chapter 5 Human Growth Hormone (hGH) Market: Application Estimates And Trend Analysis

  • 5.1 Definition & Scope
  • 5.2 Application Market Share Analysis, 2019 & 2027
  • 5.3 Segment Dashboard
  • 5.4 Global Human Growth Hormone (hGH) Market, by Application, 2016 to 2027
  • 5.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
    • 5.5.1 Growth Hormone Deficiency
      • 5.5.1.1 Growth Hormone Deficiency Market Estimates and Forecasts, 2016 to 2027 (USD Million)
      • 5.5.1.2 Adult Growth Hormone Deficiency
      • 5.5.1.2.1 Adult Growth Hormone Deficiency Market Estimates and Forecasts, 2016 to 2027 (USD Million)
      • 5.5.1.3 Pediatric Growth Hormone Deficiency
      • 5.5.1.3.1 Pediatric Growth Hormone Deficiency Market Estimates and Forecasts, 2016 to 2027 (USD Million)
    • 5.5.2 Turner Syndrome
      • 5.5.2.1 Turner Syndrome Market Estimates and Forecasts, 2016 to 2027 (USD Million)
    • 5.5.3 Idiopathic Short Stature
      • 5.5.3.1 Idiopathic Short Stature Market Estimates and Forecasts, 2016 to 2027 (USD Million)
    • 5.5.4 Prader-Willi Syndrome
      • 5.5.4.1 Prader-Willi Syndrome Market Estimates and Forecasts, 2016 to 2027 (USD Million)
    • 5.5.5 Small for Gestational Age
      • 5.5.5.1 Small for Gestational Age Market Estimates and Forecasts, 2016 to 2027 (USD Million)
    • 5.5.6 Others
      • 5.5.6.1 Others Market Estimates and Forecasts, 2016 to 2027 (USD Million)

Chapter 6 Human Growth Hormone (hGH) Market: Distribution Channel Estimates And Trend Analysis

  • 6.1 Definition & Scope
  • 6.2 Distribution Channel Market Share Analysis, 2019 & 2027
  • 6.3 Segment Dashboard
  • 6.4 Global Human Growth Hormone (hGH) Market, by Distribution Channel, 2016 to 2027
  • 6.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
    • 6.5.1 Hospital Pharmacy
      • 6.5.1.1 Hospital Pharmacy Market Estimates and Forecasts, 2016 to 2027 (USD Million)
    • 6.5.2 Retail Pharmacy
      • 6.5.2.1 Retail Pharmacy Market Estimates and Forecasts, 2016 to 2027 (USD Million)
    • 6.5.3 Online Pharmacy
      • 6.5.3.1 Online Pharmacy Market Estimates and Forecasts, 2016 to 2027 (USD Million)
    • 6.5.4 Specialty Pharmacy
      • 6.5.4.1 Specialty Pharmacy Market Estimates and Forecasts, 2016 to 2027 (USD Million)

Chapter 7 Human Growth Hormone (hGH) Market: Regional Estimates & Trend Analysis

  • 7.1 Regional Market Snapshot
  • 7.2 Regional Market Share and Leading Players, 2019
    • 7.2.1 North America
    • 7.2.2 Europe
    • 7.2.3 Latin America
    • 7.2.4 Asia Pacific
    • 7.2.5 Middle East & Africa
  • 7.3 Market Share Analysis by Country, 2019
    • 7.3.1 North America
      • 7.3.1.1 U.S.
      • 7.3.1.2 Canada
    • 7.3.2 Europe
      • 7.3.2.1 U.K.
      • 7.3.2.2 Germany
      • 7.3.2.3 Spain
      • 7.3.2.4 France
      • 7.3.2.5 Italy
      • 7.3.2.6 Russia
    • 7.3.3 Latin America
      • 7.3.3.1 Brazil
      • 7.3.3.2 Mexico
      • 7.3.3.3 Argentina
    • 7.3.4 Asia Pacific
      • 7.3.4.1 Japan
      • 7.3.4.2 China
      • 7.3.4.3 India
      • 7.3.4.4 South Korea
      • 7.3.4.5 Singapore
      • 7.3.4.6 Australia
    • 7.3.5 Middle East & Africa
      • 7.3.5.1 South Africa
      • 7.3.5.2 Saudi Arabia
      • 7.3.5.3 UAE
  • 7.4 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
    • 7.4.1 North America
    • 7.4.2 Europe
    • 7.4.3 Latin America
    • 7.4.4 Asia Pacific
    • 7.4.5 Middle East & Africa
  • 7.5 Market Size & Forecasts, and Trend Analysis, 2019 to 2027
    • 7.5.1 North America
      • 7.5.1.1 North America Market Size & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
      • 7.5.1.2 U.S.
      • 7.5.1.2.1 U.S. Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
      • 7.5.1.2.2 U.S. Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.1.3 Canada
      • 7.5.1.3.1 Canada Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
      • 7.5.1.3.2 Canada Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
    • 7.5.2 Europe
      • 7.5.2.1 Europe Market Size & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
      • 7.5.2.2 U.K.
      • 7.5.2.2.1 U.K. Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
      • 7.5.2.2.2 U.K. Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.2.3 Germany
      • 7.5.2.3.1 Germany Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
      • 7.5.2.3.2 Germany Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.2.4 Spain
      • 7.5.2.4.1 Spain Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
      • 7.5.2.4.2 Spain Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.2.5 France
      • 7.5.2.5.1 France Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
      • 7.5.2.5.2 France Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.2.6 Italy
      • 7.5.2.6.1 Italy Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
      • 7.5.2.6.2 Italy Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.2.7 Russia
      • 7.5.2.7.1 Russia Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
      • 7.5.2.7.2 Russia Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
    • 7.5.3 Latin America
      • 7.5.3.1 Latin America Market Size & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
      • 7.5.3.2 Brazil
      • 7.5.3.2.1 Brazil Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
      • 7.5.3.2.2 Brazil Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.3.3 Mexico
      • 7.5.3.3.1 Mexico Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
      • 7.5.3.3.2 Mexico Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.3.4 Argentina
      • 7.5.3.4.1 Argentina Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
      • 7.5.3.4.2 Argentina Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
    • 7.5.4 Asia Pacific
      • 7.5.4.1 Asia Pacific Market Size & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
      • 7.5.4.2 Japan
      • 7.5.4.2.1 Japan Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
      • 7.5.4.2.2 Japan Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.4.3 China
      • 7.5.4.3.1 China Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
      • 7.5.4.3.2 China Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.4.4 India
      • 7.5.4.4.1 India Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
      • 7.5.4.4.2 India Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.4.5 South Korea
      • 7.5.4.5.1 South Korea Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
      • 7.5.4.5.2 South Korea Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.4.6 Singapore
      • 7.5.4.6.1 Singapore Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
      • 7.5.4.6.2 Singapore Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.4.7 Australia
      • 7.5.4.7.1 Australia Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
      • 7.5.4.7.2 Australia Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
    • 7.5.5 Middle East & Africa
      • 7.5.5.1 Middle East & Africa Market Size & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
      • 7.5.5.2 South Africa
      • 7.5.5.2.1 South Africa Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
      • 7.5.5.2.2 South Africa Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.5.3 Saudi Arabia
      • 7.5.5.3.1 Saudi Arabia Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
      • 7.5.5.3.2 Saudi Arabia Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)
      • 7.5.5.4 UAE
      • 7.5.5.4.1 UAE Market Size & Forecasts and Trend Analysis, By Application, 2016 to 2027 (USD million)
      • 7.5.5.4.2 UAE Market Size & Forecasts and Trend Analysis, By Distribution Channel, 2016 to 2027 (USD million)

Chapter 8 COMPANY PROFILE

  • 8.1 Company Profiles
    • 8.1.1 Novo Nordisk A/S
      • 8.1.1.1 Company overview
      • 8.1.1.2 Financial Performance
      • 8.1.1.3 Product benchmarking
      • 8.1.1.4 Strategic initiatives
    • 8.1.2 Pfizer, Inc.
      • 8.1.2.1 Company overview
      • 8.1.2.2 Financial Performance
      • 8.1.2.3 Product benchmarking
      • 8.1.2.4 Strategic initiatives
    • 8.1.3 Eli Lilly and Company
      • 8.1.3.1 Company overview
      • 8.1.3.2 Financial Performance
      • 8.1.3.3 Product benchmarking
      • 8.1.3.4 Strategic initiatives
    • 8.1.4 Sandoz International GmbH
      • 8.1.4.1 Company overview
      • 8.1.4.2 Financial Performance
      • 8.1.4.3 Product benchmarking
      • 8.1.4.4 Strategic initiatives
    • 8.1.5 Merck KGaA
      • 8.1.5.1 Company overview
      • 8.1.5.2 Financial Performance
      • 8.1.5.3 Product benchmarking
      • 8.1.5.4 Strategic initiatives
    • 8.1.6 Genentech, Inc.
      • 8.1.6.1 Company overview
      • 8.1.6.2 Financial Performance
      • 8.1.6.3 Product benchmarking
      • 8.1.6.4 Strategic initiatives
    • 8.1.7 Ferring B.V.
      • 8.1.7.1 Company overview
      • 8.1.7.2 Financial Performance
      • 8.1.7.3 Product benchmarking
      • 8.1.7.4 Strategic initiatives
    • 8.1.8 Ipsen
      • 8.1.8.1 Company overview
      • 8.1.8.2 Financial Performance
      • 8.1.8.3 Product benchmarking
      • 8.1.8.4 Strategic initiatives

List of Tables

  • Table 1 List of key distributors and channel partners
  • Table 2 List of key emerging companies'/technology disruptors/innovators
  • Table 3 North America human growth hormone (hGH) market, by country, 2016 - 2027 (USD Million)
  • Table 4 North America human growth hormone (hGH) market, by application, 2016 - 2027 (USD Million)
  • Table 5 North America human growth hormone (hGH) market, by growth hormone deficiency, 2016 - 2027 (USD Million)
  • Table 6 North America human growth hormone (hGH) market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 7 U.S. human growth hormone (hGH) market, by application, 2016 - 2027 (USD Million)
  • Table 8 U.S. human growth hormone (hGH) market, by growth hormone deficiency, 2016 - 2027 (USD Million)
  • Table 9 U.S. human growth hormone (hGH) market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 10 Canada human growth hormone (hGH) market, by application, 2016 - 2027 (USD Million)
  • Table 11 Canada human growth hormone (hGH) market, by growth hormone deficiency, 2016 - 2027 (USD Million)
  • Table 12 Canada human growth hormone (hGH) market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 13 Europe human growth hormone (hGH) market, by country, 2016 - 2027 (USD Million)
  • Table 14 Europe human growth hormone (hGH) market, by application, 2016 - 2027 (USD Million)
  • Table 15 Europe human growth hormone (hGH) market, by growth hormone deficiency, 2016 - 2027 (USD Million)
  • Table 16 Europe human growth hormone (hGH) market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 17 Germany human growth hormone (hGH) market, by application, 2016 - 2027 (USD Million)
  • Table 18 Germany human growth hormone (hGH) market, by growth hormone deficiency, 2016 - 2027 (USD Million)
  • Table 19 Germany human growth hormone (hGH) market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 20 U.K. human growth hormone (hGH) market, by application, 2016 - 2027 (USD Million)
  • Table 21 U.K. human growth hormone (hGH) market, by growth hormone deficiency, 2016 - 2027 (USD Million)
  • Table 22 U.K. human growth hormone (hGH) market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 23 France human growth hormone (hGH) market, by application, 2016 - 2027 (USD Million)
  • Table 24 France human growth hormone (hGH) market, by growth hormone deficiency, 2016 - 2027 (USD Million)
  • Table 25 France human growth hormone (hGH) market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 26 Italy human growth hormone (hGH) market, by application, 2016 - 2027 (USD Million)
  • Table 27 Italy human growth hormone (hGH) market, by growth hormone deficiency, 2016 - 2027 (USD Million)
  • Table 28 Italy human growth hormone (hGH) market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 29 Spain human growth hormone (hGH) market, by application, 2016 - 2027 (USD Million)
  • Table 30 Spain human growth hormone (hGH) market, by growth hormone deficiency, 2016 - 2027 (USD Million)
  • Table 31 Spain human growth hormone (hGH) market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 32 Russia human growth hormone (hGH) market, by application, 2016 - 2027 (USD Million)
  • Table 33 Russia human growth hormone (hGH) market, by growth hormone deficiency, 2016 - 2027 (USD Million)
  • Table 34 Russia human growth hormone (hGH) market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 35 Asia Pacific human growth hormone (hGH) market, by country, 2016 - 2027 (USD Million)
  • Table 36 Asia Pacific human growth hormone (hGH) market, by application, 2016 - 2027 (USD Million)
  • Table 37 Asia Pacific human growth hormone (hGH) market, by growth hormone deficiency, 2016 - 2027 (USD Million)
  • Table 38 Asia Pacific human growth hormone (hGH) market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 39 Japan human growth hormone (hGH) market, by application, 2016 - 2027 (USD Million)
  • Table 40 Japan human growth hormone (hGH) market, by growth hormone deficiency, 2016 - 2027 (USD Million)
  • Table 41 Japan human growth hormone (hGH) market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 42 China human growth hormone (hGH) market, by application, 2016 - 2027 (USD Million)
  • Table 43 China human growth hormone (hGH) market, by growth hormone deficiency, 2016 - 2027 (USD Million)
  • Table 44 China human growth hormone (hGH) market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 45 India human growth hormone (hGH) market, by application, 2016 - 2027 (USD Million)
  • Table 46 India human growth hormone (hGH) market, by growth hormone deficiency, 2016 - 2027 (USD Million)
  • Table 47 India human growth hormone (hGH) market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 48 Australia human growth hormone (hGH) market, by application, 2016 - 2027 (USD Million)
  • Table 49 Australia human growth hormone (hGH) market, by growth hormone deficiency, 2016 - 2027 (USD Million)
  • Table 50 Australia human growth hormone (hGH) market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 51 South Korea human growth hormone (hGH) market, by application, 2016 - 2027 (USD Million)
  • Table 52 South Korea human growth hormone (hGH) market, by growth hormone deficiency, 2016 - 2027 (USD Million)
  • Table 53 South Korea human growth hormone (hGH) market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 54 Singapore human growth hormone (hGH) market, by application, 2016 - 2027 (USD Million)
  • Table 55 Singapore human growth hormone (hGH) market, by growth hormone deficiency, 2016 - 2027 (USD Million)
  • Table 56 Singapore human growth hormone (hGH) market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 57 Latin America human growth hormone (hGH) market, by country, 2016 - 2027 (USD Million)
  • Table 58 Latin America human growth hormone (hGH) market, by application, 2016 - 2027 (USD Million)
  • Table 59 Latin America human growth hormone (hGH) market, by growth hormone deficiency, 2016 - 2027 (USD Million)
  • Table 60 Latin America human growth hormone (hGH) market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 61 Brazil human growth hormone (hGH) market, by application, 2016 - 2027 (USD Million)
  • Table 62 Brazil human growth hormone (hGH) market, by growth hormone deficiency, 2016 - 2027 (USD Million)
  • Table 63 Brazil human growth hormone (hGH) market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 64 Mexico human growth hormone (hGH) market, by application, 2016 - 2027 (USD Million)
  • Table 65 Mexico human growth hormone (hGH) market, by growth hormone deficiency, 2016 - 2027 (USD Million)
  • Table 66 Mexico human growth hormone (hGH) market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 67 Argentina human growth hormone (hGH) market, by application, 2016 - 2027 (USD Million)
  • Table 68 Argentina human growth hormone (hGH) market, by growth hormone deficiency, 2016 - 2027 (USD Million)
  • Table 69 Argentina human growth hormone (hGH) market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 70 MEA human growth hormone (hGH) market, by country, 2016 - 2027 (USD Million)
  • Table 71 MEA human growth hormone (hGH) market, by application, 2016 - 2027 (USD Million)
  • Table 72 MEA human growth hormone (hGH) market, by growth hormone deficiency, 2016 - 2027 (USD Million)
  • Table 73 MEA human growth hormone (hGH) market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 74 South Africa human growth hormone (hGH) market, by application, 2016 - 2027 (USD Million)
  • Table 75 South Africa human growth hormone (hGH) market, by growth hormone deficiency, 2016 - 2027 (USD Million)
  • Table 76 South Africa human growth hormone (hGH) market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 77 Saudi Arabia human growth hormone (hGH) market, by application, 2016 - 2027 (USD Million)
  • Table 78 Saudi Arabia human growth hormone (hGH) market, by growth hormone deficiency, 2016 - 2027 (USD Million)
  • Table 79 Saudi Arabia human growth hormone (hGH) market, by distribution channel, 2016 - 2027 (USD Million)
  • Table 80 UAE human growth hormone (hGH) market, by application, 2016 - 2027 (USD Million)
  • Table 81 UAE human growth hormone (hGH) market, by growth hormone deficiency, 2016 - 2027 (USD Million)
  • Table 82 UAE human growth hormone (hGH) market, by distribution channel, 2016 - 2027 (USD Million)

List of Figures

  • Fig. 1 Human Growth Hormone (hGH) market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Human growth hormone (hGH) market snapshot (2019)
  • Fig. 9 Human growth hormone (hGH) market: Segment snapshot (2019)
  • Fig. 10 Competitive Insights (2019)
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Penetration and growth prospect mapping
  • Fig. 14 Human growth hormone (hGH) market driver impact
  • Fig. 15 Human growth hormone (hGH) market restraint impact
  • Fig. 16 Human growth hormone (hGH) industry challenges
  • Fig. 17 Porter's Five Forces Analysis
  • Fig. 18 SWOT Analysis, By Factor (Political & legal Economic and technological)
  • Fig. 19 Strategic alliance analysis
  • Fig. 20 Recent developments & impact analysis, by key market participants
  • Fig. 21 Key company market share analysis, 2019
  • Fig. 22 Company market position analysis
  • Fig. 23 Definition and scope, by product
  • Fig. 24 Product market share analysis, 2019 & 2027
  • Fig. 25 Segment dashboard
  • Fig. 26 Global human growth hormone (hGH) market, by application, 2016 - 2027 (USD Million)
  • Fig. 27 Growth Hormone Deficiency market size & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 28 Adult Growth Hormone Deficiency market size & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 29 Pediatric Hormone Deficiency market size & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 30 Turner Syndrome market size & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 31 Idiopathic Short Stature market size & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 32 Prader-Willi Syndrome market size & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 33 Small for Gestational Age market size & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 34 Others market size & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 35 Global human growth hormone (hGH) market, by distribution channel, 2016 - 2027 (USD Million)
  • Fig. 36 Hospital pharmacy market size & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 37 Retail pharmacy market size & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 38 Online pharmacy market size & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 39 Specialty pharmacy market size & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 40 Human growth hormone (hGH) market: Snapshot, 2019
  • Fig. 41 North America human growth hormone (hGH) market share and leading players, 2019
  • Fig. 42 Europe human growth hormone (hGH) market share and leading players, 2019
  • Fig. 43 Asia Pacific human growth hormone (hGH) market share and leading players, 2019
  • Fig. 44 Latin America human growth hormone (hGH) market share and leading players, 2019
  • Fig. 45 Middle East and Africa human growth hormone (hGH) market share and leading players, 2019
  • Fig. 46 North America market share analysis by country, 2019
  • Fig. 47 Europe market share analysis by country, 2019
  • Fig. 48 Asia Pacific market share analysis by country, 2019
  • Fig. 49 Latin America market share analysis by country, 2019
  • Fig. 50 Middle East and Africa market share analysis by country, 2019
  • Fig. 51 North America SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 52 Europe SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 53 Asia Pacific SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 54 Latin America SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 55 Middle East and Africa SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 56 North America market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 57 U.S. market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 58 Canada market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 59 Europe market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 60 U.K. market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 61 Germany market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 62 Spain market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 63 France market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 64 Italy market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 65 Russia market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 66 Asia Pacific market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 67 China market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 68 Japan market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 69 India market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 70 Australia market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 71 South Korea market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 72 Singapore market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 73 Latin America market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 74 Brazil market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 75 Mexico market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 76 Argentina market size, & forecasts and trend analysis, 2016 to 2027 (USD Million))
  • Fig. 77 Middle East and Africa market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 78 South Africa market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 79 Saudi Arabia market size, & forecasts and trend analysis, 2016 to 2027 (USD Million)
  • Fig. 80 UAE market size, & forecasts and trend analysis, 2016 to 2027(USD Million)